Intec Pharma Ltd.
Sector: Biotechnology - Drug Delivery
Medical Field: General Health
Technological Field: Oral Drug Delivery
Year Established: 2000
Intec Pharma is the developer of a breakthrough oral delivery platform that extends the absorption window in the gastrointestinal tract to deliver controlled release, gastric retention for a wide range of new and existing molecules. Intec's breakthrough Accordion Pill ™ platform technology opens new opportunities for companies whose drug development has been hindered by the challenge of limited absorption, and offers an important added value by extending product life cycle management opportunities in the ethical and generic drug markets.
The Accordion Pill ™ technology has undergone exhaustive exploratory and clinical trials that demonstrated clear proof of the concept. The technology deployed is based on a patented polymer matrix that extends the length of time an active ingredient remains in the stomach and in the upper part of the small intestine. This significantly improves the absorption, as well as the bioavailability, of many drugs to enable better treatment modalities in many diseases. Intec's core Accordion Pill ™ platform and applications under development are part of its diverse portfolio of intellectual property.